Showing results (191-200 of 203) with videos related to
Sort By:
Pageof 21
Acta Pharmacologica Sinica|July 15, 2022
Discovery of toxoflavin, a potent IRE1α inhibitor acting through structure-dependent oxidative inhibitionKai-Long Jiang, Chang-Mei Liu, Li-Tong Nie, et al.Oncogene|December 12, 2018
Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathwayZhan Yang, Chang-Bao Qu, Yong Zhang, et al.Journal of Experimental & Clinical Cancer Research : CR|January 4, 2021
CDK13 upregulation-induced formation of the positive feedback loop among circCDK13, miR-212-5p/miR-449a and E2F5 contributes to prostate carcinogenesisJin-Chun Qi, Zhan Yang, Tao Lin, et al.Carbohydrate Polymers|July 22, 2022
Aspidopterys obcordata vine inulin fructan affects urolithiasis by modifying calcium oxalate crystallizationPeng Sun, Shang-Gao Liao, Rao-Qiong Yang, et al.Bioorganic & Medicinal Chemistry Letters|March 29, 2018
Discovery of 4-ethoxy-7H-pyrrolo[2,3-d]pyrimidin-2-amines as potent, selective and orally bioavailable LRRK2 inhibitorsXiao Ding, Luigi Piero Stasi, Ming-Hsun Ho, et al.Bioorganic & Medicinal Chemistry Letters|December 8, 2018
5-Substituted-N-pyridazinylbenzamides as potent and selective LRRK2 inhibitors: Improved brain unbound fraction enables efficacyXiao Ding, Luigi Piero Stasi, Xuedong Dai, et al.Journal of Orthopaedic Surgery (Hong Kong)|December 9, 2020
Management for lumbar spinal stenosis: Protocol for a network meta-analysis and systematic reviewFei-Long Wei, Ya Liu, Cheng-Pei Zhou, et al.Acta Pharmacologica Sinica|July 23, 2024
In vivo proximity proteomics uncovers palmdelphin (PALMD) as a Z-disc-associated mitigator of isoproterenol-induced cardiac injuryCong-Ting Guo, Blake D Jardin, Jun-Sen Lin, et al.The Plant Journal : for Cell and Molecular Biology|April 14, 2017
Proteogenomic analysis reveals alternative splicing and translation as part of the abscisic acid response in Arabidopsis seedlingsFu-Yuan Zhu, Mo-Xian Chen, Neng-Hui Ye, et al.Bioorganic & Medicinal Chemistry Letters|August 5, 2017
Discovery of 5-substituent-N-arylbenzamide derivatives as potent, selective and orally bioavailable LRRK2 inhibitorsXiao Ding, Xuedong Dai, Kai Long, et al.Pageof 21